UBS Group
SHACU

UBS Group’s SCP & CO Healthcare Acquisition Company Unit SHACU Stock Holding History

UBS Group’s Portfolio SHACU Stock Details SHACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-884
Closed -$9K – 11735
2022
Q3 		$9K Hold
884
– – ﹤0.01% 8667
2022
Q2 		$9K Hold
884
– – ﹤0.01% 8246
2022
Q1 		$9K Hold
884
– – ﹤0.01% 8624
2021
Q4 		$9K Hold
884
– – ﹤0.01% 8982
2021
Q3 		$9K Sell
884
-1,891
-68% -$18.9K ﹤0.01% 8150
2021
Q2 		$28K Sell
2,775
-135
-5% -$1.35K ﹤0.01% 7016
2021
Q1 		$29K Buy
+2,910
New +$29.6K ﹤0.01% 7051

UBS Group's SHACU Position: Q4 2022 in Review

UBS Group sold out of SCP & CO Healthcare Acquisition Company Unit (SHACU) in Q4 2022, closing a stake of 884 shares — an estimated $9K sold.

UBS Group first reported a position in SHACU in Q1 2021 and held it in 7 quarters. The position peaked at $29K in Q1 2021. 0 funds tracked by Wall St. Rank hold SHACU as of Q4 2022.

  • UBS Group reported no remaining SCP & CO Healthcare Acquisition Company Unit position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 884 SCP & CO Healthcare Acquisition Company Unit shares in Q4 2022, an estimated $9K.
  • UBS Group first reported a position in SCP & CO Healthcare Acquisition Company Unit in Q1 2021 and held it in 7 quarters.
  • UBS Group's SCP & CO Healthcare Acquisition Company Unit position peaked at $29K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Unit as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.